Press Releases

2019

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Rubius Therapeutics Appoints Anne Prener, M.D., Ph.D., to its Board of Directors

Rubius Therapeutics 12.18.2019

Rubius Therapeutics Appoints Maiken Keson-Brookes as Chief Legal Officer and Corporate Secretary

Rubius Therapeutics 11.12.2019

Rubius Therapeutics Appoints Kris Elverum as Senior Vice President of Business Development and Strategy

Rubius Therapeutics 07.25.2019

Rubius Therapeutics Announces Issuance of Multiple U.S. Patents for its Red Cell Therapeutic Programs

Rubius Therapeutics 06.05.2019

Rubius Therapeutics Announces Extensive Preclinical Data for Three Red Cell Therapeutic Oncology Programs at the 2019 American Association for Cancer Research Annual Meeting

Rubius Therapeutics 04.02.2019

Rubius Therapeutics Announces FDA Clearance of Investigational New Drug Application for First-Ever Red Cell Therapeutic, RTX-134, for Treatment of Phenylketonuria

Rubius Therapeutics 03.11.2019

Rubius Therapeutics Highlights Upcoming 2019 Milestones at the 37th Annual J.P. Morgan Healthcare Conference

Rubius Therapeutics 01.07.2019

Loading Animation
Loading
Process Companies
Preemptive Health & Medicine Pioneering Intelligence Pioneering Medicines Flagship Fellowship
Content People About Join Us Contact Careers Press